Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | HMBD-001 |
| Trade Name | |
| Synonyms | HMBD001|HMBD 001 |
| Drug Descriptions |
HMBD-001 is a monoclonal antibody that binds ERBB3 (HER3) and prevents heterodimer formation, potentially inhibiting tumor growth (Mol Cancer Ther 2021;20(12 Suppl):Abstract nr P197). |
| DrugClasses | HER3 (ERBB3) Antibody 28 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + Docetaxel + HMBD-001 | Cetuximab Docetaxel HMBD-001 | 0 | 1 |
| Docetaxel + HMBD-001 | Docetaxel HMBD-001 | 0 | 2 |
| Gemcitabine + HMBD-001 + Nab-paclitaxel | Gemcitabine HMBD-001 Nab-paclitaxel | 0 | 1 |
| HMBD-001 | HMBD-001 | 0 | 2 |